Development of S-Adenosyl-L-methionine (SAM)-reinforced Probiotic Yogurt Using Bifidobacterium bifidum BGN4

  • Kim, Ji-Youn (Department of Food and Nutrition, Research Institute of Human Ecology, College of Human Ecology, Seoul National University) ;
  • Seo, Han-Seok (Department of Food and Nutrition, Research Institute of Human Ecology, College of Human Ecology, Seoul National University) ;
  • Seo, Min-Jeong (Department of Food and Nutrition, Research Institute of Human Ecology, College of Human Ecology, Seoul National University) ;
  • Suh, Joo-Won (Department of Biological Science, Institute of Bioscience and Biotechnology, Myongji University) ;
  • Hwang, In-Kyeong (Department of Food and Nutrition, Research Institute of Human Ecology, College of Human Ecology, Seoul National University) ;
  • Ji, Geun-Eog (Department of Food and Nutrition, Research Institute of Human Ecology, College of Human Ecology, Seoul National University)
  • 발행 : 2008.10.31

초록

S-Adenosyl-L-methionine (SAM) exerts several beneficial effects on depression, chronic diseases, and cognitive impairments. Bifidobactrium bifidum BGN4 reportedly produces higher amounts of SAM than any other lactic acid bacterium used in yogurt. The aim of this study was to develop a SAM-reinforced probiotic yogurt using Bifidobacterium. The sensory aspects of the yogurt via response surface methodology (RSM) and the texture and SAM content of the yogurt were assessed. Based on the sensory assessments for sweetness, sourness, and thickness evaluated by 48 panelists, the optimized conditions for preparation of SAM-reinforced yogurt were 4.0-4.4%(w/w) sugar, 3.2-3.5%(w/w) skim milk, and a pH of 4.7-4.8. The SAM content of the developed yogurt was 0.05 nmol/mL. In conclusion, SAM-reinforced probiotic yogurt may provide a vehicle for the potential exploitation of the benefits of increased dietary SAM.

키워드

참고문헌

  1. Gorman JM. Gender differences in depression and response to psychotropic medication. Gend. Med. 3: 93-109 (2006) https://doi.org/10.1016/S1550-8579(06)80199-3
  2. WHO. Part 1. Ten Statistical Highlights in Global Public Health. World Health Statistics 2007. World Health Organization, Geneva, Switzerland. p.16 (2007)
  3. Cassano P, Fava M. Depression and public health: An overview. J. Psychosom. Res. 53: 849-857 (2002) https://doi.org/10.1016/S0022-3999(02)00304-5
  4. Bottiglieri T, Hyland K. S-Adenosylmethionine levels in psychiatric and neurological disorders: A review. Acta Neurol. Scand. (Suppl.) 154: 19-26 (1994)
  5. Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of ademethionine (S-adenosylmethionine) in neurological disorders. Drugs 48: 137-152 (1994) https://doi.org/10.2165/00003495-199448020-00002
  6. Fetrow CW, Avila JR. Efficacy of the dietary supplement Sadenosyl-L-methionine. Ann. Pharmacother. 35: 1414-1425 (2001) https://doi.org/10.1345/aph.1Z443
  7. Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: A review of the evidence. Am. J. Clin. Nutr. 76: 1158-1161 (2002) https://doi.org/10.1093/ajcn/76.5.1158S
  8. Williams AL, Girard C, Jui D, Sabina A, Katz DL. SAdenosylmethionine (SAMe) as treatment for depression: A systematic review. Clin. Invest. Med. 28: 132-139 (2005)
  9. Lu SC, Mato JM. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol 35: 227-234 (2005) https://doi.org/10.1016/j.alcohol.2005.03.011
  10. Mato JM, Lu SC. Role of S-adenosyl-L-methionine in liver health and injury. Hepatology 45: 1306-1312 (2007) https://doi.org/10.1002/hep.21650
  11. Bradley JD, Flusser D, Katz BP, Schumacher HR Jr, Brandt KD, Chambers MA, Zonay LJ. A randomized, double blind, placebo controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by oral SAM therapy in patients with knee osteoarthritis. J. Rheumatol. 21: 905-911 (1994)
  12. Morelli V, Naguin C, Weaver V. Alternative therapies for traditional disease states: Osteoarthritis. Am. Fam. Physician 67: 339-344 (2003)
  13. Bottiglieri T, Godfrey P, Flynn T, Carney MW, Toone BK, Reynolds EH. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: Effects of treatment with parenteral and oral Sadenosylmethionine. J. Neurol. Neurosurg. Ps. 53: 1096-1098 (1990) https://doi.org/10.1136/jnnp.53.12.1096
  14. Morrison LD, Smith DD, Kish SJ. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. J. Neurochem. 67: 1328-1331 (1996) https://doi.org/10.1046/j.1471-4159.1996.67031328.x
  15. Kim JY, Suh JW, Ji GE. Evaluation of S-adenosyl-L-methionine production by Bifidobacterium bifidum BGN4. Food Sci. Biotechnol. 17: 184-187 (2008)
  16. Kim H, Kwack K, Kim DY, Ji GE. Oral probiotic bacterial administration suppressed allergic responses in an ovalbumininduced allergy mouse model. FEMS Immunol. Med. Mic. 45: 259-267 (2005) https://doi.org/10.1016/j.femsim.2005.05.005
  17. Kim H, Lee SY, Ji GE. Timing of Bifidobacterium administration influences the development of allergy to ovalbumin in mice. Biotechnol. Lett. 27: 1361-1367 (2005) https://doi.org/10.1007/s10529-005-3682-9
  18. Kim N, Kunisawa J, Kweon M-N, Ji GE, Kiyono H. Oral feeding of Bifidobacterium bifidum (BGN4) prevents $CD4^+$ $CD45RB^{high}$ T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation. Clin. Immunol. 123: 30-39 (2007) https://doi.org/10.1016/j.clim.2006.11.005
  19. Logan AC, Katzman M. Major depressive disorder: Probiotics may be an adjuvant therapy. Med. Hypotheses 64: 533-538 (2005) https://doi.org/10.1016/j.mehy.2004.08.019
  20. You HJ, Oh DK, Ji GE. Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium bifidum BGN4. FEMS Microbiol. Lett. 240: 131-136 (2004) https://doi.org/10.1016/j.femsle.2004.09.020
  21. Karnovsky MJ. A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy. J. Cell Biol. 27: 137A-138A (1965)
  22. Kim KH, Shin WC, Park YS, Yoon SS. In situ detection and differential counts of Bifidobacterium spp. using bromocresol green, a pH-dependent indicator. Food Sci. Biotechnol. 16: 99-103 (2007)
  23. Shaker RR, Jumah RY, Abu-Jdayil B. Rheological properties of plain yogurt during coagulation process: Impact of fat content and preheat treatment of milk. J. Food Eng. 44: 175-180 (2000) https://doi.org/10.1016/S0260-8774(00)00022-4
  24. Yazici F, Akgun A. Effect of some protein based fat replacers on physical, chemical, textural, and sensory properties of strained yoghurt. J. Food Eng. 62: 245-254 (2004) https://doi.org/10.1016/S0260-8774(03)00237-1
  25. Saint-Eve A, Martin N, Levy C, Souchon I. How can protein ratio affect aroma release, physical properties, and perceptions of yoghurt? Dev. Food Sci. 43: 391-394 (2006) https://doi.org/10.1016/S0167-4501(06)80092-0
  26. Mohameed HA, Abu-Jdayil B, Al-Shawabkeh A. Effect of solids concentration on the rheology of labneh (concentrated yogurt) produced from sheep milk. J. Food Eng. 61: 347-352 (2004) https://doi.org/10.1016/S0260-8774(03)00139-0
  27. Haque A, Richardson RK, Morris ER. Effect of fermentation temperature on the rheology of set and stirred yogurt. Food Hydrocolloid 15: 593-602 (2001) https://doi.org/10.1016/S0268-005X(01)00090-X
  28. Sodini I, Remeuf F, Haddad S, Corrieu G. The relative effect of milk base, starter, and process on yogurt texture: A review. Crit. Rev. Food Sci. 44: 113-137 (2004) https://doi.org/10.1080/10408690490424793
  29. Akin MB, Akin MS, Kirmaci Z. Effects of inulin and sugar levels on the viability of yogurt and probiotic bacteria and the physical and sensory characteristics in probiotic ice-cream. Food Chem. 104: 93-99 (2007) https://doi.org/10.1016/j.foodchem.2006.11.030
  30. Afonso IM, Maia JM. Rheological monitoring of structure evolution and development in stirred yoghurt. J. Food Eng. 42: 183-190 (1999) https://doi.org/10.1016/S0260-8774(99)00118-1
  31. Kalviainen N, Roininen K, Tuorila H. The relative importance of texture, taste, and aroma on a yogurt-type snack food preference in the young and the elderly. Food Qual. Prefer. 14: 177-186 (2003) https://doi.org/10.1016/S0950-3293(02)00049-6